Tamura A, Takahara Y, Mogi K, Katsumata M. Radiation-induced valvular disease is the logical consequence of irradiation. Gen Thorac Cardiovasc Surg. 2007;55:53–6.
Article
Google Scholar
Armanious MA, Mohammadi H, Khodor S, Oliver DE, Johnstone PA, Fradley MG. Cardiovascular effects of radiation therapy. Curr Probl Cancer. 2018;42(4):433–42.
Article
Google Scholar
Copeland KA, Hosmane VR, Jurkovitz C, et al. Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center. Clin Cardiol. 2013;36(4):217–21.
Article
Google Scholar
Bouillon K, Haddy N, Delaloge S, et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57(4):445–52.
Article
Google Scholar
Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of congestive heart failure in patients aged ≥ 62 years with unoperated severe valvular aortic stenosis. Am J Cardiol. 1993;72:846–8.
Article
CAS
Google Scholar
Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of patients with heart failure and unoperated severe aortic valvular regurgitation and relation to ejection fraction. Am J Cardiol. 1994;74:286–8.
Article
CAS
Google Scholar
Zamorano JL, Lancellotti P, Munoz DR, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ES Committee for practice guidelines. Eur Heart J. 2016;37:2768–801.
Article
Google Scholar
Donnellan E, Masri A, Johnston DR, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6:5.
Article
Google Scholar
FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery. Available: https://www.fda.gov/news-events/press-announcements/fda-expands-indication-several-transcatheter-heart-valves- patients- low-risk-death-or-major [Accessed April 2020].
Agrawal N, Kattel S, Waheed S, et al. Clinical outcomes after transcatheter aortic valve replacement in cancer survivors treated with ionizing radiation. Cardiooncology. 2019;5:1.
Google Scholar
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
Article
Google Scholar
Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438–54.
Article
Google Scholar
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa-scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses; 2016. Available: http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf [Accessed April 2020].
Google Scholar
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Article
CAS
Google Scholar
Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Article
Google Scholar
Dijos M, Reynaud A, Leroux L, et al. Efficacy and follow-up of transcatheter aortic valve implantation in patients with radiation-induced aortic stenosis. Open Heart. 2015;2(1):e000252.
Article
Google Scholar
Bouleti C, Amsallem M, Touati A, et al. Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation. Heart. 2016;102(13):1044–51.
Article
CAS
Google Scholar
Gajanana D, Rogers T, Attaran S, et al. Transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis and prior external chest radiation. Cardiovasc Revasc Med. 2019;20(5):376–80.
Article
Google Scholar
Landes U, Iakobishvili Z, Vronsky D, et al. Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis. JACC Cardiovasc Interv. 2019;12(1):78–86.
Article
Google Scholar
Mangner N, Woitek FJ, Haussig S, et al. Impact of active cancer disease on the outcome of patients undergoing transcatheter aortic valve replacement. J Interv Cardiol. 2018;31(2):188–96.
Article
Google Scholar
Watanabe Y, Kozuma K, Hioki H, et al. Comparison of results of transcatheter aortic valve implantation in patients with versus without active cancer. Am J Cardiol. 2016;118(4):572–7.
Article
Google Scholar
Berkovitch A, Guetta V, Barbash IM, et al. Favorable short-term and long-term outcomes among patients with prior history of malignancy undergoing transcatheter aortic valve implantation. J Invasive Cardiol. 2018;30(3):105–9.
PubMed
Google Scholar
Biancari F, Dahlbacka S, Juvonen T, et al. Favorable outcome of cancer patients undergoing transcatheter aortic valve replacement. Int J Cardiol. 2020;1(19):35546–9.
Google Scholar
Guha A, Dey AK, Arora S, et al. Contemporary trends and outcomes of percutaneous and surgical aortic valve replacement in patients with cancer. J Am Heart Assoc. 2020;9(2):e014248.
Article
Google Scholar
Zhang D, Guo W, Al-Hijji MA, et al. Outcomes of patients with severe symptomatic aortic valve stenosis after chest radiation: transcatheter versus surgical aortic valve replacement. J Am Heart Assoc. 2019;8(10):e012110.
Article
Google Scholar
Bendary A, Ramzy A, Bendary M, Salem M. Transcatheter aortic valve replacement in patients with severe aortic stenosis and active cancer: a systemic review and meta-analysis. Open Heart. 2020;7:e001131.
Article
Google Scholar
Balan P, Zhao Y, Johnson S, et al. The society of thoracic surgery risk score as a predictor of 30-day mortality in transcatheter vs surgical aortic valve replacement: a single-center experience and its implications for the development of a TAVR risk-prediction model. J Invasive Cardiol. 2017;29(3):109–14.
PubMed
Google Scholar
Puls M, Sobisiak B, Bleckmann A, et al. Impact of frailty on short- and long-term morbidity and mortality after transcatheter aortic valve implantation: risk assessment by Katz index of activities of daily living. EuroIntervention. 2014;10(5):609–19.
Article
Google Scholar
Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21):2831–7.
Article
CAS
Google Scholar
Reed GW, Masri A, Griffin BP, Kapadia SR, Ellis SG, Desai MY. Long-term mortality in patients with radiation-associated coronary artery disease treated with percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9:6.
Article
Google Scholar
Daitoku K, Fukui K, Ichinoseki I, Munakata M, Takahashi S, Fukuda I. Radiotherapy-induced aortic valve disease associated with porcelain aorta. Jpn J Thorac Cardiovasc Surg. 2004;52(7):349–52.
Article
Google Scholar
Demir OM, Iannopollo G, Mangieri A, et al. The role of cerebral embolic protection devices during Transcatheter aortic valve replacement. Front Cardiovasc Med. 2018;5:150.
Article
Google Scholar
Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol. 2004;22:3339–48.
Google Scholar
Maan A, Refaat MM, Heist EK, et al. Incidence and predictors of pacemaker implantation in patients undergoing Transcatheter aortic valve replacement. Pacing Clin Electrophysiol. 2015;38(7):878–86.
Article
Google Scholar
El-Sherif O, Xhaferllari I, Sykes J, et al. (18) F-FDG cardiac PET inflammation imaging in a canine model of radiation induced cardiac disease associated with breast cancer radiotherapy. Am J Physiol Heart Circ Physiol. 2019;316(3):H586–95.
Article
CAS
Google Scholar
Taunk NK, Haffty BG, Kostis JB, Goyal S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015;5:39.
Article
Google Scholar
Durand E, Doutriaux M, Bettinger N, et al. Incidence, prognostic impact, and predictive factors of readmission for heart failure after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10(23):2426–36.
Article
Google Scholar
Yeh ET. Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med. 2006;57:485–98.
Article
CAS
Google Scholar
Chirakaranjanakorn S, Popovic ZB, Wu W, et al. Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease. J Thorac Cardiovasc Surg. 2015;149:1643–5.
Article
Google Scholar
Canada JM, Trankle CR, Carbone S, et al. Determinants of cardiorespiratory fitness following thoracic radiotherapy in lung or breast cancer survivors. Am J Cardiol. 2020;125(6):988–96.
Article
CAS
Google Scholar